Celldex Therapeutics CLDX
NASDAQ CLDX
$30.65 -0.59 (-1.89%)
At close: Nov 10, 2026 · 4:00 PM EST

Celldex Therapeutics (CLDX) Net Equity Issued and Repurchased (2009 - 2026)

Updated

Celldex Therapeutics' Net Equity Issued and Repurchased came in at $324.66 million for Q2 2026, compared with $63,000 a year earlier.

Analysis

Celldex Therapeutics (CLDX) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Celldex Therapeutics reported Net Equity Issued and Repurchased of $327.11 million; for FY2025, it was $2.39 million, down 99.5% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -57.5% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $441.45 million in FY2024 (+102.1%), $218.46 million in FY2023, $4.08 million in FY2022 (-98.5%) and $272.37 million in FY2021 (+59.1%).
  • The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased in data going back to Q3 2010.
  • Year-over-year, Net Equity Issued and Repurchased increased in three of the last five quarters, with growth averaging 111.2%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q4 2021 (growth of 868.2%), and the weakest in Q4 2024 (a decline of 99.8%).
  • Business Quant data shows CLDX's Net Equity Issued and Repurchased at $327,000 (Q1 2026), $1.35 million (Q4 2025) and $774,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Celldex Therapeutics 2.41 Bn 69.14 Mn - 1.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.12 Mn
Jun 30, 2026 324.66 Mn
Mar 31, 2026 327,000.00
Dec 31, 2025 1.35 Mn
Sep 30, 2025 774,000.00
Jun 30, 2025 63,000.00
Mar 31, 2025 202,000.00
Dec 31, 2024 386,000.00
Sep 30, 2024 1.24 Mn
Dec 31, 2023 217.37 Mn
Sep 30, 2023 257,000.00
Jun 30, 2023 133,000.00
Mar 31, 2023 694,000.00
Dec 31, 2022 1.40 Mn
Sep 30, 2022 2.31 Mn
Jun 30, 2022 71,000.00
Mar 31, 2022 304,000.00
Dec 31, 2021 426,000.00
Sep 30, 2021 271.90 Mn
Jun 30, 2021 -25,000.00
API Access

Celldex Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CLDX&period=max&api_key=YOUR_API_KEY